← Open Payments lookup

NEIL MALLIS: Open Payments

NPI 1881633576 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$528 in 25 payments from 10 companies in 2025. Trend: 2023 $239 · 2024 $205 · 2025 $528

Food & beverage: $528
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP6$108
ABBVIE INC.5$105
Amgen Inc.3$76
Sumitomo Pharma America, Inc.3$68
Janssen Pharmaceuticals, Inc2$67
Axsome Therapeutics, Inc.2$41
PFIZER INC.1$19
GlaxoSmithKline, LLC.1$17
Novo Nordisk Inc1$15
Lilly USA, LLC1$14

Products named: VRAYLAR, AIRSUPRA, REPATHA, GEMTESA, SPRAVATO, Auvelity, BREZTRI, PAXLOVID.

Industry payments across PA — which companies pay providers there.